Sting Agonist For The Treatment Of Relapsed/Refractory Acute Myeloid Leukemia And High-Risk Myelodysplastic Syndrome: A First-In-Clinic Phase 1 Study Of Gsk3745417
GSK-3745417
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Sting Agonist For The Treatment Of Relapsed/Refractory Acute Myeloid Leukemia And High-Risk Myelodysplastic Syndrome: A First-In-Clinic Phase 1 Study Of Gsk3745417 ### Output: GSK-3745417